Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. VACH
VACH logo

VACH Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
12.020
Open
12.020
VWAP
11.01
Vol
13.54K
Mkt Cap
332.06M
Low
10.500
Amount
149.01K
EV/EBITDA(TTM)
--
Total Shares
31.63M
EV
695.57M
EV/OCF(TTM)
--
P/S(TTM)
--
Voyager Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. It may pursue an initial business combination in any business or industry. The Company has not conducted any operations and has generated no revenues.
Show More

Events Timeline

(ET)
2026-03-19
09:40:00
Voyager Acquisition Corp Trading Halted Due to Volatility Trading Pause
select
2026-03-13 (ET)
2026-03-13
06:10:00
Voyager Acquisition Approves Merger with Veraxa Biotech
select
2026-03-11 (ET)
2026-03-11
10:00:00
Voyager Acquisition Corp Trading Halted Due to Volatility Trading Pause
select
2025-07-17 (ET)
2025-07-17
09:11:38
Voyager Acquisition, VERAXA announce filing of Form F-4 registration statement
select

News

seekingalpha
8.5
03-13seekingalpha
Voyager Acquisition's Merger with Veraxa Biotech Approved
  • Merger Approval: Voyager Acquisition (VACHU) received approval for its merger with Veraxa Biotech AG on March 12, with the combined entity expected to trade on Nasdaq under the symbol VRXA, marking a significant step in the company's strategic expansion.
  • Share Redemption Status: Approximately 99.67% of Class A shares (25.2 million shares) were submitted for redemption and not withdrawn, indicating strong investor interest and participation in the merger, which enhances the capital base of the post-merger company.
  • Trust Account Balance: Following the redemption of 25.2 million shares, about $0.89 million will remain in the trust account, providing liquidity support for the merged entity and ensuring operational stability and growth potential.
  • Transaction Conditions: The closing of this transaction is contingent upon Nasdaq approval and other customary closing conditions, highlighting the company's focus on compliance and market adaptability to ensure a smooth merger process.
moomoo
8.5
03-13moomoo
VOYAGER ACQUISITION CORPORATION RECEIVES GREEN LIGHT FOR BUSINESS MERGER WITH VERAXA BIOTECH AG
  • Business Combination Announcement: Voyager Acquisition Corporation has announced the approval of its business combination with Verax BioTech.

  • Strategic Partnership: This merger aims to enhance Voyager's capabilities and expand its market presence in the biotechnology sector.

Newsfilter
8.5
03-02Newsfilter
VERAXA Biotech Merger with Voyager Approved by Shareholders
  • Merger Approval: VERAXA Biotech received shareholder approval for its merger with Veraxa Biotech Holding AG and the issuance of new shares at the Extraordinary General Meeting on February 27, 2026, marking a significant step towards its business combination with Voyager Acquisition Corp.
  • Capital Increase: The EGM also approved an ordinary capital increase of up to CHF 223,400, which is expected to provide necessary funding for the combined company, thereby enhancing its competitive position in the cancer therapy market.
  • Stable Management Team: Post-merger, VERAXA will continue to be led by CEO Christoph Antz, ensuring operational continuity and strategic direction during the integration process, further solidifying its innovative position in antibody-drug conjugates and bispecific T cell engagers.
  • Future Outlook: Upon completion of the merger, the new company is expected to trade on NASDAQ under the symbol “VRXA,” allowing VERAXA to expand its influence in the cancer treatment market and meet the growing demand for safer and more effective cancer therapies.
Globenewswire
7.0
2025-11-07Globenewswire
Shareholder Notice: M&A Class Action Firm Ongoing Investigation into the Merger Involving PBBK, VACH, LCTC, and SMLR
  • Class Action Firm Recognition: Monteverde & Associates PC, led by attorney Juan Monteverde, is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report and has successfully recovered millions for shareholders.

  • PB Bankshares Investigation: The firm is investigating PB Bankshares Inc. regarding its sale to Norwood Financial Corp., where shareholders can choose between shares or cash, with a shareholder vote scheduled for December 10, 2025.

  • Other Mergers and Acquisitions: The firm is also involved in cases related to Voyager Acquisition Corp.'s merger with Veraxa Biotech AG, Lifeloc Technologies' merger with Electronic Systems Technology, and Semler Scientific's sale to Strive, Inc.

  • Contact Information: Shareholders with concerns or seeking more information can contact Juan Monteverde via email or phone, with services offered at no cost or obligation.

Newsfilter
8.5
2025-07-17Newsfilter
VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC
  • Business Combination Announcement: VERAXA Biotech AG and Voyager Acquisition Corp. have filed a registration statement with the SEC regarding their proposed business combination, which is expected to close in Q4 2025, valuing VERAXA at approximately $1.64 billion.

  • Transaction Details: The merger will result in existing VERAXA shareholders receiving shares in the combined company without cash proceeds, while VERAXA anticipates access to around $253 million in cash held by Voyager, subject to shareholder approvals and customary closing conditions.

Globenewswire
8.5
2025-07-17Globenewswire
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Voyager Acquisition Corp. (NASDAQ: VACH)
  • Class Action Firm Overview: Monteverde & Associates PC, led by attorney Juan Monteverde, is recognized as a top firm for recovering millions for shareholders and is currently investigating Voyager Acquisition Corp.'s merger with Veraxa Biotech AG.

  • Legal Services Offered: The firm emphasizes its successful track record in class action lawsuits and invites shareholders to contact them for free consultations regarding their concerns about the merger.

Valuation Metrics

The current forward P/E ratio for Voyager Acquisition Corp (VACH.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Voyager Acquisition Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

AI Analysis
Annual
Quarterly

Whales Holding VACH

W
W. R. Berkley Corporation
Holding
VACH
+6.74%
3M Return
M
Magnetar Capital Partners, LP
Holding
VACH
-2.48%
3M Return
W
Westchester Capital Management, LLC
Holding
VACH
-4.27%
3M Return
W
Wolverine Asset Management, LLC
Holding
VACH
-5.60%
3M Return
A
Aristeia Capital, LLC
Holding
VACH
-9.96%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Voyager Acquisition Corp (VACH) stock price today?

The current price of VACH is 10.5 USD — it has decreased -9.56

What is Voyager Acquisition Corp (VACH)'s business?

Voyager Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. It may pursue an initial business combination in any business or industry. The Company has not conducted any operations and has generated no revenues.

What is the price predicton of VACH Stock?

Wall Street analysts forecast VACH stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for VACH is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Voyager Acquisition Corp (VACH)'s revenue for the last quarter?

Voyager Acquisition Corp revenue for the last quarter amounts to -873.51K USD, increased 1132.43

What is Voyager Acquisition Corp (VACH)'s earnings per share (EPS) for the last quarter?

Voyager Acquisition Corp. EPS for the last quarter amounts to USD, decreased -100.00

How many employees does Voyager Acquisition Corp (VACH). have?

Voyager Acquisition Corp (VACH) has 0 emplpoyees as of March 22 2026.

What is Voyager Acquisition Corp (VACH) market cap?

Today VACH has the market capitalization of 332.06M USD.